BOLERO-2 abstract should cite erratum-corrected subgroup wording
fact knowledge 4360dd15 clinical-trials erratum evidence-chain
结论
对于 BOLERO-2 这篇文章,若要引用摘要中的最终可用文本,应以 PMC4713958 所给出的 correct sentence 为准,而不是原始摘要句。
逐字对照结果
原始摘要句在 “all prospectively defined subgroups” 后面列出:
- “including patients with visceral metastases, patients with recurrence during or within 12 months of completion of adjuvant therapy, and irrespective of age.”
erratum 将其改为:
- “including patients with visceral metastases, and irrespective of age.”
影响范围
- 被更正的是 subgroup wording。
- “[investigator review: 7.8 versus 3.2 months ...; central review: 11.0 versus 4.1 months ...]” 这段 PFS 数值在 erratum 中 未改变。
- 因此,若论证 PFS 结果,可继续使用原摘要/正文中的数值;若引用摘要里的分组表述,应采用更正后的版本。
可复现依据
- Erratum 全文:PMC4713958
- 原文条目入口:24158787(Europe PMC 记录)
最终表述建议
当写成可引用的摘要转述时,优先写:
''BOLERO-2 的 erratum 仅修正了摘要中的亚组措辞:应写作 “including patients with visceral metastases, and irrespective of age,” 而不应保留原先把 recurrence during or within 12 months of adjuvant therapy 也并入 prospectively defined subgroups 的表述。''